Furthermore, HIF1A silencing in PC‐3 cells enhanced CC3 levels (Fig EV3D), demonstrating that pharmacological inhibition of HIF1A induces profound anticancer effects in castration‐resistant prostate tumor cells. This evidence concerns the gene HIF1A and prostate neoplasm.